Works matching AU Tefferi, Ayalew

Results: 499
    1
    2
    3
    4

    Systemic Mastocytosis.

    Published in:
    Archives of Pathology & Laboratory Medicine, 2007, v. 131, n. 5, p. 784, doi. 10.5858/2007-131-784-smacca
    By:
    • Patnaik, Mrinal M.;
    • Rindos, Michelle;
    • Kouides, Peter A.;
    • Tefferi, Ayalew;
    • Pardanani, Animesh
    Publication type:
    Article
    5
    6
    7

    The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin's lymphoma.

    Published in:
    Leukemia & Lymphoma, 2005, v. 46, n. 9, p. 1287, doi. 10.1080/10428190500126380
    By:
    • Yinlee Yoong;
    • Porrata, Luis F.;
    • Inwards, David J.;
    • Ansell, Stephen M.;
    • Micallef, Ivana N. M.;
    • Litzow, Mark R.;
    • Gertz, Morie A.;
    • Lacy, Martha Q.;
    • Dispenzieri, Angela;
    • Gastineau, Dennis A.;
    • Tefferi, Ayalew;
    • Elliott, Michelle;
    • Snow, Denis S.;
    • Hogan, Willian J.;
    • Markovic, Svetomir N.
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14

    Veno-occlusive Disease of the Liver after Blood and Marrow Transplantation: Analysis of Pre- and Post-transplant Risk Factors Associated with Severity and Results of Therapy with Tissue Plasminogen Activator.

    Published in:
    Leukemia & Lymphoma, 2002, v. 43, n. 11, p. 2099, doi. 10.1080/1042819021000032962
    By:
    • Litzow, Mark R.;
    • Repoussis, Panagiotis G.;
    • Schroeder, Georgene;
    • Schembri-Wismayer, David;
    • Batts, Kenneth P.;
    • Anderson, Peter M.;
    • Arndt, Carola A.S.;
    • Chen, Michael G.;
    • Gastineau, Dennis A.;
    • Gertz, Morie A.;
    • Inwards, David J.;
    • Lacy, Martha Q.;
    • Tefferi, Ayalew;
    • Noel, Pierre;
    • Solberg Jr., Lawrence A.;
    • Letendre, Louis;
    • Hoagland, H. Clark
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    Essential Thrombocythemia: A Review.

    Published in:
    JAMA: Journal of the American Medical Association, 2025, v. 333, n. 8, p. 701, doi. 10.1001/jama.2024.25349
    By:
    • Tefferi, Ayalew;
    • Gangat, Naseema;
    • Loscocco, Giuseppe Gaetano;
    • Guglielmelli, Paola;
    • Szuber, Natasha;
    • Pardanani, Animesh;
    • Orazi, Attilio;
    • Barbui, Tiziano;
    • Vannucchi, Alessandro Maria
    Publication type:
    Article
    29
    30

    Evaluating the serial use of the Myelofibrosis Symptom Assessment Form for measuring symptomatic improvement: performance in 87 myelofibrosis patients on a JAK1 and JAK2 inhibitor (INCB018424) clinical trial.

    Published in:
    2011
    By:
    • Mesa RA;
    • Kantarjian H;
    • Tefferi A;
    • Dueck A;
    • Levy R;
    • Vaddi K;
    • Erickson-Viitanen S;
    • Thomas DA;
    • Cortes J;
    • Borthakur G;
    • Pardanani AD;
    • Estrov Z;
    • Verstovsek S;
    • Mesa, Ruben A;
    • Kantarjian, Hagop;
    • Tefferi, Ayalew;
    • Dueck, Amylou;
    • Levy, Richard;
    • Vaddi, Kris;
    • Erickson-Viitanen, Susan
    Publication type:
    journal article
    31
    32
    33
    34
    35
    36
    37
    38
    39

    Cardiac events in newly diagnosed acute myeloid leukaemia during treatment with venetoclax + hypomethylating agents.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 4, p. 1232, doi. 10.1111/bjh.19325
    By:
    • Johnson, Isla M.;
    • Karrar, Omer;
    • Rana, Masooma;
    • Iftikhar, Moazah;
    • Chen, Sunny;
    • McCullough, Kristen;
    • Saliba, Antoine N.;
    • Al‐Kali, Aref;
    • Alkhateeb, Hassan;
    • Begna, Kebede;
    • Litzow, Mark;
    • Hogan, William J.;
    • Shah, Mithun;
    • Patnaik, Mrinal M.;
    • Pardanani, Animesh;
    • Hermann, Joerg;
    • Tefferi, Ayalew;
    • Gangat, Naseema
    Publication type:
    Article
    40

    TP53 variant allele frequency and therapy‐related setting independently predict survival in myelodysplastic syndromes with del(5q).

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 4, p. 1243, doi. 10.1111/bjh.19247
    By:
    • Tefferi, Ayalew;
    • Fleti, Farah;
    • Chan, Onyee;
    • Al Ali, Najla H.;
    • Al‐Kali, Aref;
    • Begna, Kebede H.;
    • Foran, James M.;
    • Badar, Talha;
    • Khera, Nandita;
    • Shah, Mithun;
    • Hiwase, Devendra;
    • Padron, Eric;
    • Sallman, David A.;
    • Pardanani, Animesh;
    • Arber, Daniel A.;
    • Orazi, Attilio;
    • Reichard, Kaaren K.;
    • He, Rong;
    • Ketterling, Rhett P.;
    • Gangat, Naseema
    Publication type:
    Article
    41
    42
    43
    44

    Myeloproliferative neoplasms – a global view.

    Published in:
    British Journal of Haematology, 2022, v. 198, n. 6, p. 953, doi. 10.1111/bjh.18213
    By:
    • Tefferi, Ayalew;
    • Ianotto, Jean‐Christophe;
    • Mathews, Vikram;
    • Samuelsson, Jan;
    • Szuber, Natasha;
    • Xiao, Zhijian;
    • Hokland, Peter
    Publication type:
    Article
    45

    Limited activity of fedratinib in myelofibrosis patients relapsed/refractory to ruxolitinib 20 mg twice daily or higher: A real‐world experience.

    Published in:
    British Journal of Haematology, 2022, v. 198, n. 4, p. e54, doi. 10.1111/bjh.18284
    By:
    • Gangat, Naseema;
    • McCullough, Kristen;
    • Al‐Kali, Aref;
    • Begna, Kebede H.;
    • Patnaik, Mrinal M.;
    • Litzow, Mark R.;
    • Hogan, William;
    • Shah, Mithun;
    • Alkhateeb, Hassan;
    • Mangaonkar, Abhishek;
    • Foran, James M.;
    • Palmer, Jeanne M.;
    • Pardanani, Animesh;
    • Tefferi, Ayalew
    Publication type:
    Article
    46
    47

    De novo isolated myeloid sarcoma: comparative analysis of survival in 19 consecutive cases.

    Published in:
    British Journal of Haematology, 2021, v. 195, n. 3, p. 413, doi. 10.1111/bjh.17742
    By:
    • Begna, Kebede H.;
    • Kittur, Jaya;
    • Yui, Jennifer;
    • Gangat, Naseema;
    • Patnaik, Mrinal M.;
    • Al‐Kali, Aref;
    • Elliott, Michelle A.;
    • Hogan, William J.;
    • Litzow, Mark R.;
    • Hook, Christopher C.;
    • Wolanskyj, Alexandra P.;
    • Howard, Matthew T.;
    • Hanson, Curtis A.;
    • Ketterling, Rhett P.;
    • Pardanani, Animesh D.;
    • Tefferi, Ayalew
    Publication type:
    Article
    48

    Updated results of the placebo‐controlled, phase III JAKARTA trial of fedratinib in patients with intermediate‐2 or high‐risk myelofibrosis.

    Published in:
    British Journal of Haematology, 2021, v. 195, n. 2, p. 244, doi. 10.1111/bjh.17727
    By:
    • Pardanani, Animesh;
    • Tefferi, Ayalew;
    • Masszi, Tamás;
    • Mishchenko, Elena;
    • Drummond, Mark;
    • Jourdan, Eric;
    • Vannucchi, Alessandro;
    • Jurgutis, Mindaugas;
    • Ribrag, Vincent;
    • Rambaldi, Alessandro;
    • Koh, Liang Piu;
    • Rose, Shelonitda;
    • Zhang, Jun;
    • Harrison, Claire
    Publication type:
    Article
    49
    50

    Clonal heterogeneity in STAG2m myeloid neoplasms: the Mayo Clinic experience.

    Published in:
    2024
    By:
    • Katamesh, Bahga;
    • Nanaa, Ahmad;
    • He, Rong;
    • Viswanatha, David;
    • Greipp, Patricia T.;
    • Bessonen, Kurt;
    • Nguyen, Phuong;
    • Jevremovic, Dragan;
    • Yi, Cecilia Arana;
    • Foran, James;
    • Begna, Kebede;
    • Gangat, Naseema;
    • Mangaonkar, Abhishek;
    • Saliba, Antoine N.;
    • Patnaik, Mrinal M.;
    • Hogan, William J;
    • Litzow, Mark;
    • Tefferi, Ayalew;
    • Shah, Mithun Vinod;
    • Alkhateeb, Hassan B
    Publication type:
    Letter